ruxolitinib
Showing 1 - 25 of 345
GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)
Not yet recruiting
- GVHD
- Acute Stem Cell Transplant Complications
- Ruxolitinib
-
Chendu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 3, 2023
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)
Not yet recruiting
- The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
- Ruxolitinib 5 MG BID Oral Tablet
- (no location specified)
Jun 13, 2023
Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)
Not yet recruiting
- Metastatic Triple-Negative Breast Carcinoma
- Breast Cancer
- Neratinib Oral Tablet
- Ruxolitinib Oral Tablet
-
Dallas, TexasBaylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023
Neuromyelitis Optica Spectrum Disorder Relapse Trial in Tianjin (Ruxolitinib)
Withdrawn
- Neuromyelitis Optica Spectrum Disorder Relapse
- Ruxolitinib
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Jun 10, 2023
Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Severe Aplastic Anemia
- +2 more
- Ruxolitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
Ruxolitinib in Patients With Myelofibrosis
Not yet recruiting
- Myelofibrosis
- Ruxolitinib
- (no location specified)
Feb 28, 2023
Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)
Not yet recruiting
- Haemophagocytic Lymphohistiocytosis
- Ruxolitinib
- (no location specified)
Feb 28, 2023
Seborrheic Dermatitis Trial in New York (Ruxolitinib 1.5% Cream)
Recruiting
- Seborrheic Dermatitis
- Ruxolitinib 1.5% Cream
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 15, 2023
Vitiligo Trial in Nice (Ruxolitinib Topical, Placebo)
Not yet recruiting
- Vitiligo
- Ruxolitinib Topical
- Placebo
-
Nice, Alpes-maritimes, FranceCHU de Nice - Hôpital de l'Archet
May 22, 2023
Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)
Approved for marketing
- Graft-versus-host Disease (GVHD)
- Ruxolitinib
- (no location specified)
Jan 26, 2023
Prurigo Trial (Ruxolitinib Cream, Vehicle Cream)
Not yet recruiting
- Prurigo
- Ruxolitinib Cream
- Vehicle Cream
- (no location specified)
Feb 23, 2023
Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)
Not yet recruiting
- Prurigo Nodularis
- Ruxolitinib Cream
- Vehicle Cream
- (no location specified)
Mar 1, 2023
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)
Recruiting
- MDS/MPN
- Azacitidine (AZA) with Ruxolitinib
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023
Severe Checkpoint Inhibitor Pneumonitis Trial in Beijing (Corticosteroids, Corticosteroids and Ruxolitinib)
Recruiting
- Severe Checkpoint Inhibitor Pneumonitis
- Corticosteroids
- Corticosteroids and Ruxolitinib
-
Beijing, Beijing, ChinaDepartment of Respiratory Medicine, Peking Union Medical College
Jun 12, 2023
Nonsegmental Vitiligo With Genital Involvement Trial (Ruxolitinib Cream)
Not yet recruiting
- Nonsegmental Vitiligo With Genital Involvement
- Ruxolitinib Cream
- (no location specified)
Feb 20, 2023
Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)
Not yet recruiting
- Graft Vs Host Disease
- +2 more
- Ruxolitinib
-
Saint Louis, MissouriWashington University School of Medicine
Aug 18, 2023
Atopic Dermatitis Trial in Culver City (Ruxolitinib cream, Vehicle)
Recruiting
- Atopic Dermatitis
- Ruxolitinib cream
- Vehicle
-
Culver City, CaliforniaScience37
Jan 12, 2023
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
- Ruxolitinib
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Atopic Dermatitis Trial in East Syracuse, Arlington (ruxolitinib cream)
Recruiting
- Atopic Dermatitis
- ruxolitinib cream
-
East Syracuse, New York
- +1 more
Jan 13, 2023
A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease
Not yet recruiting
- Graft-versus-Host Disease
- ruxolitinib
- (no location specified)
Jan 11, 2023
T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)
Not yet recruiting
- T-Cell Large Granular Lymphocyte Leukemia
- Ruxolitinib
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 20, 2022